Women who suffer greater menopause symptoms are more likely to experience memory and thinking problems as they age, research has suggested.Experts found that women who recalled a heavier burden of ...

A new analysis provides substantial evidence that paramagnetic rim lesions drive disability in MS and are targetable with a ...

Posters presented at the Association of Cancer Care Centers opening session covered initiatives to boost clinical trial ...

Trading commencing on the OTC Markets on March 5, 2025.Trading expected to continue under ticker symbol "NKGN" for common stock and "NKGNW" for warrants.NKGen Biotech, Inc. ("NKGen" or the "Company") ...

Phase Ib trial to evaluate CS5001 in combination with R-CHOP as a first-line treatment for diffuse large B-cell lymphoma (DLBCL), aiming to reshape the standard-of-care landscape. CS5001 is also being ...

Melanoma Companies are involved in targeted therapeutics development with respective active and inactive (dormant or ...

President Donald Trump’s pick to lead the National Institutes of Health answered sharp questions in a confirmation hearing ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

Ocugen (NASDAQ: OCGN) Q4 2024 Earnings Call Mar 05, 2025, 8:30 a.m. ET ...

Anova Enterprises, Inc. (Anova), a technology-enabled CRO dedicated to accelerating promising treatments, has announced enrollment of the first two pa ...

A study published in the Proceedings of the National Academy of Sciences has unveiled that brain aging follows a distinct yet ...